Veterinary Vaccines Market (2025-2032)
The Veterinary Vaccines Market is expected to record a CAGR of 6.1% from 2025 to 2032, reaching $11.13 billion by 2032.
- Published
- Jan 2025
- Pages
- 250
- Format
- PDF + Excel
- Report ID
- MRHC - 104935
- Base year
- 2024
- 2032 · FORECAST
- $11.13B
- 2032
- $11.13B
- CAGR 2025–2032
- 6.1%
2024 baseline · 2025–2032 forecast at 6.1% CAGR · hover a bar for the value
Key highlights
The Live Attenuated Vaccines Segment to Dominate the Veterinary Vaccines Market in 2025
The Livestock Segment to Account for the Largest Market Share in 2025
Parenteral Segment to Account for the Largest Market Share in 2025
Hospitals & Clinics Segment to Account for the Largest Market Share in 2025
Asia-Pacific to Be the Fastest-Growing Regional Market
Report summary
| Particulars | Details |
|---|---|
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025–2032 |
| Market Size (2032) | USD 11.13 billion |
| CAGR (2025–2032) | 6.1% |
| Format | PDF, Excel & Cloud Portal · 250 pages |
| Segments Covered | By Type: Live Attenuated Vaccines, Inactive Vaccines, Recombinant Vaccines, Other Vaccines · By Animal Type: Livestock Ruminants, Poultry, Porcine, Other Livestock, Canine, Feline · By Administration Route: Parenteral, Oral, Intranasal · By Distribution Channel: Veterinary Hospitals & Clinics, Pharmacies, Mobile Veterinary Units |
| Countries Covered | Europe (RoE), Asia-Pacific (RoAPAC), Latin America (RoLATAM) |
| Key Companies | Zoetis Inc. (U.S.), Virbac, Ceva Santé Animale, Boehringer Ingelheim International GmbH, Phibro Animal Health Corporation (U.S.), Merck & Co., Inc (U.S.), Elanco Animal Health Inc. (U.S.), Vetoquinol, Neogen Corporation (U.S.), Indian Immunologicals Ltd. |
Report overview
Segments covered: type, animal type, administration route, distribution channel. Regions: Europe, Asia-Pacific, Latin America.
Veterinary vaccines are integral to the veterinary healthcare industry as they help prevent diseases and their spread. They also reduce the risk of transmission of infections from household pets to their owners. Several types of vaccines, such as live attenuated, inactive, recombinant, and other vaccines, are used to immunize livestock and companion animals. The most preferred administration route for animal vaccines is parenteral, as animals are reluctant to take medications, including vaccines.
The growth of this market is driven by the increasing livestock population, growing pet adoption, increasing prevalence of diseases in animals, and growing demand for animal-derived food products. Additionally, increasing awareness regarding animal health and growing expenditure on animal health and pet insurance are expected to create growth opportunities for the stakeholders in this market. However, the high cost of manufacturing and vaccine storage restrain the growth of this market. Low awareness regarding animal health in developing countries is a major challenge to market growth.
Report infographic
Market dynamics
1 factors across 1 forceGrowing Expenditure on Animal Health and Pet Insurance Provides Opportunities for the Players Operating in the Market
Global veterinary healthcare expenditure has increased over the years. People are willing to spend substantial money on caring for their pets. According to the American Pet Products Association, people in the U.S. spent approximately USD 90.5 billion on their pets in 2018, which increased to USD 136.8 billion in 2022. Veterinary care (including vaccines) and product sales accounted for USD 35.9 billion in 2022, an increase of 4.7% compared to 2021.
Moreover, according to the North American Pet Health Insurance Association (NAPHIA), the pet health insurance sector in the U.S. and Canada registered a combined gross written premium of USD 3.51 billion in 2020, up 23.5% from USD 2.84 billion in 2021. The total number of pets insured reached 5.36 million in 2022, an increase of 21.7% from 4.4 million in 2021.
Furthermore, there was a rise in pet adoption in Australia. According to Animal Medicines Australia, pet ownership in Australia increased to 68.7% of households having pets in 2022 from 61% in 2019. This increase led to a rise in pet-related expenditures & adoption of pet insurance in Australia. For instance, total expenditure on pet health increased to USD 33.2 billion in 2022 from USD 13 billion in 2019 annually. In 2022, veterinary services, including routine vaccinations, increased to USD 4.7 billion in 2022 compared to USD 2.6 billion in 2019.
The growing expenditure on pet health and veterinary services and growing adoption of pet insurance is expected to increase the utilization of routine vaccinations, providing an opportunity for the players operating in the veterinary vaccines market.
Table of contents
12 chapters · 100 sections · 250 pages · click to expandSegmental analysis
| Segment | Largest share (2025) | Fastest growth (2025–2032) |
|---|---|---|
| By Type | Live Attenuated Vaccines | — |
| By Animal Type | Livestock | — |
| By Administration Route | Parenteral | — |
| Other segments | Hospitals & Clinics | — |
By Type
- The Live Attenuated Vaccines Segment to Dominate the Veterinary Vaccines Market in 2025
- Live attenuated vaccines use weakened or dormant organisms, which help create a blueprint to fight the infections against the disease by initiating cell-mediated immune responses.
- Live attenuated vaccines are very effective in dangerous and deadly diseases in animals.
- Live attenuated vaccines imitate the natural infections they can help prevent, creating a strong and long-lasting immune response.
- Thus, a higher preference for live attenuated vaccines supports its largest share.
By Animal Type
- The Livestock Segment to Account for the Largest Market Share in 2025
- The factors contributing to the segment’s large share are the large population of poultry and farm animals in developed and developing countries, high awareness regarding animal health amongst farmers in developed countries, and the growing demand for animal-derived food products globally.
- There has been a growing demand for animal-derived food products globally.
- To ensure good quality, disease food products, vaccinations play a crucial role in keeping farm animals healthy and disease-free preventing loss to farmers.
- The demand for animal-derived foods, such as meat, milk products, and eggs, has increased recently.
- According to the Food and Agriculture Organization of the United Nations (FAO), feeding the world population (7.9 billion) would require raising overall agri-food production by 50–70%, and global poultry meat consumption is expected to increase from 3,818.60 thousand tonnes in 2020 to 5,134.81 thousand tonnes in 2032.
By Administration Route
- Parenteral Segment to Account for the Largest Market Share in 2025
- The segment's large share is attributed to the animals’ especially pets’ reluctance towards oral vaccines and easy and high vaccine absorption through the intramuscular route.
- Muscle tissues have a generous blood supply; therefore, the vaccines administered are readily absorbed into the bloodstream.
Other segments
- Hospitals & Clinics Segment to Account for the Largest Market Share in 2025
- The segment's large share is attributed to animal owners' high preference for hospitals & clinics, easy accessibility, and the growing burden of diseases in animals.
- To control and prevent the growing incidence of zoonotic diseases and prevent the deterioration of animal health by disease infections, vaccines play a crucial role.
- Veterinarians in hospitals and clinics are highly skilled, and the vaccines must be administered only by licensed professionals.
- Veterinary hospitals and clinics provide animal vaccination services, as vaccines should be administered in certain periods.
Geographic analysis
Asia-Pacific
Fastest growthThe high growth of the Asia-Pacific veterinary vaccines market is attributed to the growing population of pet animals, growing demand and consumption of animal-derived food proteins, presence of large exporters of animal products, government initiatives to improve agricultural and animal husbandry outcomes, and the rising incidence of various zoonotic diseases in the region. Asia-Pacific to Be the Fastest-Growing Regional Market
North America
Largest shareIn 2025, North America is expected to dominate the veterinary vaccines market, while Asia-Pacific is expected to record the highest CAGR during the forecast period.
Competitive landscape
- Zoetis Inc. (U.S.)
- Virbac · France
- Ceva Santé Animale · France
- Boehringer Ingelheim International GmbH · Germany
- Phibro Animal Health Corporation (U.S.)
- Merck & Co., Inc (U.S.)
- Elanco Animal Health Inc. (U.S.)
- Vetoquinol · France
- Neogen Corporation (U.S.)
- Indian Immunologicals Ltd. · India
Frequently asked questions
The veterinary vaccines market report covers market sizes & forecasts for live attenuated, inactive, recombinant, and other vaccines used for animal immunization. The veterinary vaccines market study includes the value analysis of various segments and subsegments of the veterinary vaccines market at the regional and country levels.
Cite this report
Meticulous Research. (2025). Veterinary Vaccines Market - Global Opportunity Analysis and Industry Forecast (2025-2032) (Report No. MRHC - 104935). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/veterinary-vaccines-market-5618